OVID
Price:
$1.135
Market Cap:
$80.60M
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collabo...[Read more]
Industry
Biotechnology
IPO Date
2017-05-05
Stock Exchange
NASDAQ
Ticker
OVID
According to Ovid Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.47. This represents a change of 22.18% compared to the average of -2.02 of the last 4 quarters.
The mean historical PE Ratio of Ovid Therapeutics Inc. over the last ten years is -17.29. The current -2.47 PE Ratio has changed 1.33% with respect to the historical average. Over the past ten years (40 quarters), OVID's PE Ratio was at its highest in in the June 2024 quarter at 1.79. The PE Ratio was at its lowest in in the March 2016 quarter at -16.30.
Average
-17.29
Median
-2.85
Minimum
-130.29
Maximum
1.76
Discovering the peaks and valleys of Ovid Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 139.50%
Maximum Annual PE Ratio = 1.76
Minimum Annual Increase = -244.49%
Minimum Annual PE Ratio = -130.29
Year | PE Ratio | Change |
---|---|---|
2023 | -4.34 | 70.42% |
2022 | -2.55 | -244.49% |
2021 | 1.76 | -205.43% |
2020 | -1.67 | -39.10% |
2019 | -2.75 | 139.50% |
2018 | -1.15 | -61.08% |
2017 | -2.95 | -72.50% |
2016 | -10.71 | -41.29% |
2015 | -18.25 | -86.00% |
The current PE Ratio of Ovid Therapeutics Inc. (OVID) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.71
5-year avg
-1.91
10-year avg
-17.29
Ovid Therapeutics Inc.’s PE Ratio is less than CytomX Therapeutics, Inc. (7.38), less than Spero Therapeutics, Inc. (21.59), greater than Neoleukin Therapeutics, Inc. (-5.86), less than Instil Bio, Inc. (-2.12), less than NextCure, Inc. (-0.55), less than Assembly Biosciences, Inc. (-2.47), less than Achilles Therapeutics plc (-0.63), less than Nuvation Bio Inc. (-1.41), less than Connect Biopharma Holdings Limited (8.01),
Company | PE Ratio | Market cap |
---|---|---|
7.38 | $93.91M | |
21.59 | $63.79M | |
-5.86 | $8.20M | |
-2.12 | $159.62M | |
-0.55 | $31.93M | |
-2.47 | $100.81M | |
-0.63 | $43.16M | |
-1.41 | $923.88M | |
8.01 | $61.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ovid Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ovid Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Ovid Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Ovid Therapeutics Inc. (OVID)?
What is the highest PE Ratio for Ovid Therapeutics Inc. (OVID)?
What is the 3-year average PE Ratio for Ovid Therapeutics Inc. (OVID)?
What is the 5-year average PE Ratio for Ovid Therapeutics Inc. (OVID)?
How does the current PE Ratio for Ovid Therapeutics Inc. (OVID) compare to its historical average?